Orthogonal Functionalization of Oxo-Graphene Nanoribbons.

Lucia Merkel, Christof Neumann, Christian E Halbig, Anton Habel, Xin Chen, Andrey Turchanin, Siegfried Eigler

Abstract read

In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Orthogonal Functionalization of Oxo-Graphene Nanoribbons.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lucia MerkelInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID https://orcid.org/0009-0000-2911-6582

Christof NeumannInstitute of Physical Chemistry, Friedrich Schiller University Jena, Lessingstraße 10, 07743, Jena, Germany.ORCID https://orcid.org/0000-0002-3598-7656

Christian E HalbigInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID https://orcid.org/0000-0001-9842-6971

Anton HabelInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.

Xin ChenInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID https://orcid.org/0000-0003-3031-533X

Andrey TurchaninInstitute of Physical Chemistry, Friedrich Schiller University Jena, Lessingstraße 10, 07743, Jena, Germany.ORCID https://orcid.org/0000-0003-2388-1042

Siegfried EiglerInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID https://orcid.org/0000-0002-0536-8256

Funding

Bundesministerium für Wirtschaft und Klimaschutz ZF4817401VS9Deutsche Forschungsgemeinschaft 249559513Deutsche Forschungsgemeinschaft 313713174European Science Foundation 0080, 0051

6 · The paper itself

Abstract

Oxo-graphene nanoribbons (oxo-GNRs) can be prepared by the oxidative unzipping of single-walled carbon nanotubes. We present an orthogonal functionalization method for the functionalization of the rims and the π-surface, respectively, what is only possible due to the high rim portion in oxo-GNRs. In particular, X-ray photoelectron spectroscopy could be used to follow the reaction and detect the marker atoms contained in the addends. We propose that the reported orthogonal functionalization strategy can also be applied on other oxo-functionalized carbon materials, such as graphene quantum dots, or reduced graphene oxide flakes.

Indexed as

GrapheneNanoribbonsNanostructuresOrthogonal functionalization

Identifiers

PMID39556476

DOI10.1002/chem.202403645

PMCPMC11753386

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.